{"adverse_reactions":["Sincerus Florida, LLC. Adverse reactions dws"],"components":["Active, inactive ds"],"effective_time":"20190516","id":"890786c2-de41-f838-e053-2995a90ad280","instructions_for_use":["Direcfor use sc"],"openfda":{},"package_label_principal_display_panel":["NDC 72934- 5138-4 LIDOCAINE USP 15% / PHENYLEPHRINE HCL USP 0.25% / PRILOCAINE USP 5%. Ointment 120gm cs"],"set_id":"890786c2-de40-f838-e053-2995a90ad280","spl_product_data_elements":["LIDOCAINE 15% / PHENYLEPHRINE HCL 0.25% / PRILOCAINE 5% LIDOCAINE 15% / PHENYLEPHRINE HCL 0.25% / PRILOCAINE 5% LIDOCAINE LIDOCAINE"],"version":"1"}